Cullen/Frost Bankers’s Tenet Healthcare THC Stock Holding History

Cullen/Frost Bankers’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.5K	Buy	500 +100	+25%	+$18.4K	﹤0.01%	734
2026 Q1	$75.5K	Sell	400 -159	-28%	-$33.5K	﹤0.01%	715
2025 Q4	$111K	Buy	559 +6	+1%	+$1.21K	﹤0.01%	663
2025 Q3	$112K	Sell	553 -48	-8%	-$8.52K	﹤0.01%	626
2025 Q2	$106K	Buy	601 +191	+47%	+$28.8K	﹤0.01%	628
2025 Q1	$55.1K	Hold	410	–	–	﹤0.01%	706
2024 Q4	$51.8K	Buy	410 +10	+3%	+$1.49K	﹤0.01%	695
2024 Q3	$66.5K	Buy	+400	New	+$60.5K	﹤0.01%	662
2022 Q4	–	Sell	-700	Closed	-$36K	–	1202
2022 Q3	$36K	Hold	700	–	–	﹤0.01%	764
2022 Q2	$37K	Hold	700	–	–	﹤0.01%	752
2022 Q1	$60K	Hold	700	–	–	﹤0.01%	710
2021 Q4	$57K	Hold	700	–	–	﹤0.01%	731
2021 Q3	$47K	Hold	700	–	–	﹤0.01%	781
2021 Q2	$47K	Hold	700	–	–	﹤0.01%	794
2021 Q1	$36K	Hold	700	–	–	﹤0.01%	779
2020 Q4	$28K	Hold	700	–	–	﹤0.01%	805
2020 Q3	$17K	Hold	700	–	–	﹤0.01%	853
2020 Q2	$13K	Hold	700	–	–	﹤0.01%	874
2020 Q1	$10K	Hold	700	–	–	﹤0.01%	729
2019 Q4	$27K	Hold	700	–	–	﹤0.01%	734
2019 Q3	$15K	Hold	700	–	–	﹤0.01%	781
2019 Q2	$14K	Buy	+700	New	+$16.1K	﹤0.01%	774

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cullen/Frost Bankers's THC Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Tenet Healthcare (THC) stake by 25% in Q2 2026, buying an estimated $18.4K and bringing the position to 500 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Cullen/Frost Bankers first reported a position in THC in Q2 2019 and has held it in 22 quarters since. The position peaked at $112K in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Cullen/Frost Bankers held 500 shares of Tenet Healthcare worth $93.5K as of Q2 2026.
Cullen/Frost Bankers bought 100 Tenet Healthcare shares in Q2 2026, an estimated $18.4K.
Tenet Healthcare made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #734 holding.
Cullen/Frost Bankers first reported a position in Tenet Healthcare in Q2 2019 and has held it in 22 quarters since.
Cullen/Frost Bankers's Tenet Healthcare position peaked at $112K in Q3 2025.
681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.